HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy
Neuromuscular Disorders · 2023
DOI: 10.1016/j.nmd.2023.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuromuscular Disorders, 2023. Verfasst von Xiaona Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Inborn Errors, Muscular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Neutral lipid-storage disease with myopathy (NLSDM) is an autosomal recessive neuromuscular disorder caused by mutations in PNPLA2, and the average age at onset is 30 years. To date, only eight patients with childhood-onset NLSDM have been reported in detail. We investigated 3 unreported patients with NLSDM detected in childhood and reviewed 8 childhood-onset and 82 adult-onset patients with NLSDM documented in the literature. In the childhood-onset cohort, NLSDM presented initially as asymptomatic or paucisymptomatic hyperCKemia in 6/11 patients, and follow-up data showed onset of muscle weakness in 6/11 childhood-onset patients. In the adult-onset cohort, 95.1% (78/82) of patients showed muscle weakness. Cardiac involvement developed in 6/11 childhood-onset patients. Hepatomegaly was observed in 3/11 childhood-onset patients. Serum creatine kinase levels were elevated greater than five-fold of the upper limit of normal (ULN) in most childhood-onset patients and were elevated to less than ten-fold of the ULN in most adult-onset patients. Peripheral blood smears and muscle biopsies showed cytoplasmic lipid droplets in leukocytes and myocytes. NLSDM can present in children with asymptomatic or paucisymptomatic hyperCKemia before the onset of muscle weakness. The presence of lipid droplets in leucocytes (Jordans' anomaly) aids in diagnosing and confirming the pathogenicity of PNPLA2 variants of uncertain significance. There were no clear genotype-phenotype correlations in patients with NLSDM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
- Department of Pediatrics, Peking University First Hospital, Beijing, China.
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China. Electronic address: renxiaotun@bch.com.cn.
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China. Electronic address: lujunlan@aliyun.com.
Förderung
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Fu, X., Yang, X., Wang, X., Jia, B., Ma, W., Xiong, H., Fang, F., Ren, X., & Lv, J. (2023). HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2023.07.007
Vancouver
Fu X, Yang X, Wang X, Jia B, Ma W, Xiong H, et al. HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy. Neuromuscular Disorders. 2023. doi:10.1016/j.nmd.2023.07.007
BibTeX
@article{Fu2023,
author = {Fu, Xiaona and Yang, Xinying and Wang, Xiaofei and Jia, Bingbing and Ma, Wenna and Xiong, Hui and Fang, Fang and Ren, Xiaotun and Lv, Junlan},
title = {HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy},
journal = {Neuromuscular Disorders},
year = {2023},
doi = {10.1016/j.nmd.2023.07.007}
}
EUVIMED